91ĸƵ Surgical secures more than $200M to accelerate growth
91ĸƵ Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital
91ĸƵ Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital
Versius—the second most utilised soft tissue surgical robot in the world—has now been used in over 30,000 surgical cases globally
91ĸƵ Surgical and KEBOMED expand existing partnership to include Sweden, so more patients can benefit from robotic-assisted minimal access surgery with Versius.
91ĸƵ Surgical announces the appointment of Massimiliano Colella as Chief Executive Officer and member of the Board of Directors.
91ĸƵ Surgical launches the Ultrasonic Dissector, a robotic advanced energy instrument delivering ultrasonic energy to cut and coagulate tissue, as part of its Versius Plus offering.
The All-Wales National Robotic Assisted Surgery Programme has now completed more than 500 robotic-assisted surgical cases with Versius. The Programme is a national partnership between 91ĸƵ Surgical and NHS Wales to improve surgical outcomes and transform the experience of surgery for thousands of patients. Through the programme, Versius is used for robotic assisted minimal access surgery at Betsi Cadwaladr University Health Board’s Ysbyty Gwynedd Hospital, Cardiff & Vale University Health Board’s Cardiff University Hospital; and Cwm Taf Morgannwg University Health Board’s Royal Glamorgan Hospital.
The U.S. Food and Drug Administration (FDA) has granted 91ĸƵ Surgical marketing authorization for the Versius Surgical System (Versius) in cholecystectomy, paving the way for the next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.
91ĸƵ Surgical announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.
Milton Keynes University Hospital NHS Foundation Trust, he first hospital in England to introduce Versius have purchased a second Versius system, and surpassed the 800 case milestone with Versius
91ĸƵ Surgical has appointed Markus Bauman as Chief Legal & Business Affairs Officer and will join 91ĸƵ’s executive leadership team. Michelle Paknad has been appointed as Senior Vice President, Global Business Development.